Literature DB >> 19506008

Kinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaques.

Anne E Boyer1, Conrad P Quinn, Alex R Hoffmaster, Thomas R Kozel, Elke Saile, Chung K Marston, Ann Percival, Brian D Plikaytis, Adrian R Woolfitt, Maribel Gallegos, Patrick Sabourin, Lisa G McWilliams, James L Pirkle, John R Barr.   

Abstract

Systemic anthrax manifests as toxemia, rapidly disseminating septicemia, immune collapse, and death. Virulence factors include the anti-phagocytic gamma-linked poly-d-glutamic acid (PGA) capsule and two binary toxins, complexes of protective antigen (PA) with lethal factor (LF) and edema factor. We report the characterization of LF, PA, and PGA levels during the course of inhalation anthrax in five rhesus macaques. We describe bacteremia, blood differentials, and detection of the PA gene (pagA) by PCR analysis of the blood as confirmation of infection. For four of five animals tested, LF exhibited a triphasic kinetic profile. LF levels (mean +/- standard error [SE] between animals) were low at 24 h postchallenge (0.03 +/- 1.82 ng/ml), increased at 48 h to 39.53 +/- 0.12 ng/ml (phase 1), declined at 72 h to 13.31 +/- 0.24 ng/ml (phase 2), and increased at 96 h (82.78 +/- 2.01 ng/ml) and 120 h (185.12 +/- 5.68 ng/ml; phase 3). The fifth animal had an extended phase 2. PGA levels were triphasic; they were nondetectable at 24 h, increased at 48 h (2,037 +/- 2 ng/ml), declined at 72 h (14 +/- 0.2 ng/ml), and then increased at 96 h (3,401 +/- 8 ng/ml) and 120 h (6,004 +/- 187 ng/ml). Bacteremia was also triphasic: positive at 48 h, negative at 72 h, and positive at euthanasia. Blood neutrophils increased from preexposure (34.4% +/- 0.13%) to 48 h (75.6% +/- 0.08%) and declined at 72 h (62.4% +/- 0.05%). The 72-h declines may establish a "go/no go" turning point in infection, after which systemic bacteremia ensues and the host's condition deteriorates. This study emphasizes the value of LF detection as a tool for early diagnosis of inhalation anthrax before the onset of fulminant systemic infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506008      PMCID: PMC2715684          DOI: 10.1128/IAI.00346-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Hematology of the normal monkey.

Authors:  G M KRISE
Journal:  Ann N Y Acad Sci       Date:  1960-05-12       Impact factor: 5.691

2.  Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences.

Authors:  Chun Kim; Nadesan Gajendran; Hans-Willi Mittrücker; Matthias Weiwad; Young-Hwa Song; Robert Hurwitz; Matthias Wilmanns; Gunter Fischer; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

3.  Sequential morphological and quantitative changes in blood and bone marrow neutrophils in dogs with acute inflammation.

Authors:  K A Gossett; P S MacWilliams; B Cleghorn
Journal:  Can J Comp Med       Date:  1985-07

4.  Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice.

Authors:  S L Welkos; R W Trotter; D M Becker; G O Nelson
Journal:  Microb Pathog       Date:  1989-07       Impact factor: 3.738

5.  Use of anthrax vaccine in the United States.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-12-15

6.  Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-11-15       Impact factor: 17.586

7.  Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts.

Authors:  M J Ardron; J C Westengard; T F Dutcher
Journal:  Am J Clin Pathol       Date:  1994-11       Impact factor: 2.493

8.  Monocyte retention and migration in pulmonary inflammation. Requirement for neutrophils.

Authors:  D E Doherty; G P Downey; G S Worthen; C Haslett; P M Henson
Journal:  Lab Invest       Date:  1988-08       Impact factor: 5.662

9.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

10.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more
  34 in total

1.  Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.

Authors:  Robyn A Stoddard; Conrad P Quinn; Jarad M Schiffer; Anne E Boyer; Jason Goldstein; Dennis A Bagarozzi; Stephen D Soroka; Leslie A Dauphin; Alex R Hoffmaster
Journal:  J Immunol Methods       Date:  2014-05-22       Impact factor: 2.303

2.  Inhibition of Interleukin 1β (IL-1β) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages.

Authors:  Soon-Duck Ha; Chantelle Reid; Shahab Meshkibaf; Sung Ouk Kim
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

3.  A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Authors:  Conrad P Quinn; Carol L Sabourin; Nancy A Niemuth; Han Li; Vera A Semenova; Thomas L Rudge; Heather J Mayfield; Jarad Schiffer; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; April M Brys; Robert E Hunt; Denyse Levesque; James E Estep; Roy E Barnewall; David M Robinson; Brian D Plikaytis; Nina Marano
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

4.  Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma.

Authors:  Alexander F Kintzer; Harry J Sterling; Iok I Tang; Ali Abdul-Gader; Andrew J Miles; B A Wallace; Evan R Williams; Bryan A Krantz
Journal:  J Mol Biol       Date:  2010-04-28       Impact factor: 5.469

Review 5.  The Bacillus cereus Group: Bacillus Species with Pathogenic Potential.

Authors:  Monika Ehling-Schulz; Didier Lereclus; Theresa M Koehler
Journal:  Microbiol Spectr       Date:  2019-05

6.  Pasteur revisited: An unexpected finding in Bacillus anthracis vaccine strains.

Authors:  Peter Thorkildson; Haley L Kinney; David P AuCoin
Journal:  Virulence       Date:  2016-05-10       Impact factor: 5.882

7.  Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Authors:  Marybeth Langer; Elizabeth Stewart Duggan; John Leland Booth; Vineet Indrajit Patel; Ryan A Zander; Robert Silasi-Mansat; Vijay Ramani; Tibor Zoltan Veres; Frauke Prenzler; Katherina Sewald; Daniel M Williams; Kenneth Mark Coggeshall; Shanjana Awasthi; Florea Lupu; Dennis Burian; Jimmy Dale Ballard; Armin Braun; Jordan Patrick Metcalf
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

8.  Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species.

Authors:  Tanya M Jelacic; Wilson J Ribot; Jennifer Chua; Anne E Boyer; Adrian R Woolfitt; John R Barr; Arthur M Friedlander
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

9.  Stereo-selective binding of monoclonal antibodies to the poly-γ-D-glutamic acid capsular antigen of Bacillus anthracis.

Authors:  Mark A Hubbard; Peter Thorkildson; William H Welch; Thomas R Kozel
Journal:  Mol Immunol       Date:  2013-04-17       Impact factor: 4.407

10.  Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.

Authors:  Haijing Hu; Stephen H Leppla
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.